Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on behavioral measures of impulsivity: Alone and in combination with alcohol

Neuropsychopharmacology

Volumn 31, Issue 5, 2006, Pages 1048-1055

  Ramaekers, Johannes G ^a,b   Kuypers, Kim P C ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Acute; Alcohol; Impulsivity; Interaction; MDMA; Risk taking

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; PLACEBO;

ADULT; ALCOHOL BLOOD LEVEL; ARTICLE; ATTENTION; CLINICAL ARTICLE; COMMISSION ERROR; CONTROLLED STUDY; DRUG ALCOHOL INTERACTION; DRUG EFFECT; DRUG WITHDRAWAL; ERROR; FEMALE; GO NO GO TASK; HIGH RISK BEHAVIOR; HUMAN; IMPULSE CONTROL DISORDER; IMPULSIVENESS; INTOXICATION; IOWA GAMBLING TASK; MALE; NEUROPSYCHOLOGICAL TEST; PERCEPTION; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; REACTION TIME; STOP SIGNAL TASK;

ACUTE DISEASE; ADULT; ALCOHOL-INDUCED DISORDERS, NERVOUS SYSTEM; BRAIN; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CROSS-OVER STUDIES; DECISION MAKING; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; ETHANOL; FEMALE; HALLUCINOGENS; HUMANS; IMPULSIVE BEHAVIOR; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEURAL INHIBITION; NEUROPSYCHOLOGICAL TESTS; PLACEBOS; PSYCHOMOTOR PERFORMANCE; REACTION TIME;

EID: 33646157498     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300894     Document Type: Article

References (47)

1. Bechara A (2004). Separate neural substrates underlie different mechanisms of performance monitoring and behavioral control. In: Ullsperger M, Falkenstein M (eds). Errors, Conflicts and the Brain. Current Opinions on Performance Monitoring (MPI special issue in human cognitive and brain sciences). Max Planck-Institut fur Kognitions und Neurowissenschaften: Leipzig. pp 55-62.
2. Bechara A, Damasio H, Damasio AR (2000). Emotion, decision making and the orbitofrontal cortex. Cereb Cortex 10: 295-307.
3. Bechara A, Dolan S, Denburg N, Hindes A, Anderson SW, Nathan PE (2001). Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia 39: 376-389.
4. Bolla KI, McCann UD, Ricaurte GA (1998). Memory impairment in abstinent MDMA ('Ecstasy') users. Neurology 51: 1532-1537.
5. Butler GK, Montgomery AM (2004). Impulsivity, risk taking and recreational 'ecstasy' (MDMA) use. Drug Alcohol Depend 76: 55-62.
6. Cole JC, Sumnall HR (2003). Altered states: the clinical effects of Ecstasy. Pharmacol Ther 98: 35-58.
7. de Wit H, Crean J, Richards JB (2000). Effects of D-amphetamine and ethanol on a measure of behavioral inhibition in humans. Behav Neurosci 114: 830-837.
8. de Wit H, Enggasser JL, Richards JB (2002). Acute administration of D-amphetamine decreases impulsivity in healthy volunteers. Neuropsychopharmacology 27: 813-825.
9. Fillmore MT, Kelly TH, Martin CA (2005). Effects of D-amphetamine in human models of information processing and inhibitory control. Drug Alcohol Depend 77: 151-159.
10. Fillmore MT, Rush CR, Hays L (2002). Acute effects of oral cocaine on inhibitory control of behavior in humans. Drug Alcohol Depend 67: 157-167.
11. Fillmore MT, Rush CR, Marczinski CA (2003). Effects of D-amphetamine on behavioral control in stimulant abusers: the role of prepotent response tendencies. Drug Alcohol Depend 71: 143-152.
12. Fillmore MT, Vogel-Sprott M (1997). Resistance to cognitive impairment under alcohol: the role of environmental consequences. Exp Clin Psychopharmacol 5: 251-255.
13. Fillmore MT, Vogel-Sprott M (1999). An alcohol model of impaired inhibitory control and its treatment in humans. Exp Clin Psychopharmacol 7: 49-55.
14. Gamella JF, Alvarez-Roldan A, Romo N (1997). The content of ecstasy in Spain. In: Korf DJ RH (ed). Proceedings of the 7th Annual Conference on Drug Use and Drug Policy. Siswo: Amsterdam.
15. Gerra G, Zaimovic A, Giucastro G, Maestri D, Monica C, Sartori R et al (1998). Serotonergic function after (+/-)3,4-methylenedioxymethamphetamine ('Ecstasy') in humans. Int Clin Psychopharmacol 13: 1-9.
16. Green AR, O'Shea E, Colado MI (2004). A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response. Eur J Pharmacol 500: 3-13.
17. Green DM, Swets JA (1966). Signal Detection Theory and Psychophysics. Wiley: New York.
18. Hernandez-Lopez C, Farre M, Roset PN, Menoyo E, Pizarro N, Ortuno J et al (2002). 3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics. J Pharmacol Exp Ther 300: 236-244.
19. Jentsch JD, Taylor JR (1999). Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berlin) 146: 373-390.
20. Lamers CT, Ramaekers JG, Muntjewerff ND, Sikkema KL, Samyn N, Read NL et al (2003). Dissociable effects of a single dose of ecstasy (MDMA) on psychomotor skills and attentional performance. J Psychopharmacol 17: 379-387.
21. Linnoila M, Virkkunen M, George T, Higley D (1993). Impulse control disorders. Int Clin Psychopharmacol 8(Suppl 1): 53-56.
22. Linnoila M, Virkkunen M, Scheinin M, Nuutila A, Rimon R, Goodwin FK (1983). Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from non-impulsive violent behavior. Life Sci 33: 2609-2614.
23. Logan BK, Couper FJ (2001). 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairment. J Forensic Sci 46: 1426-1433.
24. Logan GD (1994). On the ability to inhibit though and action: a users' guide to the stop signal paradigm. In: Dagenbach D, Carr TH (eds). Inhibitory processes in attention, memory and language. Academic Press: San Diego. pp 189-239.
25. Logan GD, Cowan WB, Davis KA (1984). On the ability to inhibit simple and choice reaction time responses: a model and a method. J Exp Psychol Hum Percept Perform 10: 276-291.
26. McCann UD, Eligulashvili V, Mertl M, Murphy DL, Ricaurte GA (1999). Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users. Psychopharmacology (Berlin) 147: 56-65.
27. McCann UD, Ridenour A, Shaham Y, Ricaurte GA (1994). Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; 'Ecstasy'): a controlled study in humans. Neuropsychopharmacology 10: 129-138.
28. Moeller FG, Dougherty DM, Steinberg JL, Swann AC, Silverman PB, Kramer LA et al (2002). Heavy 'ecstasy' use is associated with increased impulsivity. Addict Disord Treatment 1: 47-52.
29. Monterosso J, Ehrman R, Napier KL, O'Brien CP, Childress AR (2001). Three decision-making tasks in cocaine-dependent patients: do they measure the same construct? Addiction 96: 1825-1838.
30. Morgan MJ (1998). Recreational use of 'ecstasy' (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology 19: 252-264.
31. Morgan MJ (2000). Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacology (Berlin) 152: 230-248.
32. Mulvihill LE, Skilling TA, Vogel-Sprott M (1997). Alcohol and the ability to inhibit behavior in men and women. J Stud Alcohol 58: 600-605.
33. Nash JF (1990). Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis. Life Sci 47: 2401-2408.
34. Ortner CN, MacDonald TK, Olmstead MC (2003). Alcohol intoxication reduces impulsivity in the delay-discounting paradigm. Alcohol Alcohol 38: 151-156.
35. Parrott AC (2000). Human research on MDMA (3,4-methylenedioxymethamphetamine) neurotoxicity: cognitive and behavioural indices of change. Neuropsychobiology 42: 17-24.
36. Peroutka SJ, Pascoe N, Faull KF (1987). Monoamine metabolites in the cerebrospinal fluid of recreational users of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'). Res Commun Subst Abuse 8: 125-138.
37. Reneman L, Endert E, de Bruin K, Lavalaye J, Feenstra MG, de Wolff FA et al (2002). The acute and chronic effects of MDMA ('ecstasy') on cortical 5-HT2A receptors in rat and human brain. Neuropsychopharmacology 26: 387-396.
38. Ricaurte GA, Finnegan KT, Irwin I, Langston JW (1990). Aminergic metabolites in cerebrospinal fluid of humans previously exposed to MDMA: preliminary observations. Ann NY Acad Sci 600: 699-708; discussion 708-710.
39. Richards JB, Zhang L, Mitchell SH, de Wit H (1999). Delay or probability discounting in a model of impulsive behavior: effect of alcohol. J Exp Anal Behav 71: 121-143.
40. Ridderinkhof KR, van den Wildenberg WP, Segalowitz SJ, Carter CS (2004). Neurocognitive mechanisms of cognitive control: the role of prefrontal cortex in action selection, response inhibition, performance monitoring, and reward-based learning. Brain Cogn 56: 129-140.
41. Steele TD, McCann UD, Ricaurte GA (1994). 3,4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): pharmacology and toxicology in animals and humans. Addiction 89: 539-551.
42. Steele TD, Nichols DE, Yim GK (1987). Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain. Biochem Pharmacol 36: 2297-2303.
43. Swann AC, Bjork JM, Moeller FG, Dougherty DM (2002). Two models of impulsivity: relationship to personality traits and psychopathology. Biol Psychiatry 51: 988-994.
44. Topp L, Hando J, Dillon P, Roche A, Solowij N (1999). Ecstasy use in Australia: patterns of use and associated harm. Drug Alcohol Depend 55: 105-115.
45. Verkes RJ, Gijsman HJ, Pieters MS, Schoemaker RC, de Visser S, Kuijpers M et al (2001). Cognitive performance and serotonergic function in users of ecstasy. Psychopharmacology (Berlin) 153: 196-202.
46. Volkow ND, Wang GJ, Fowler JS (1997a). Imaging studies of cocaine in the human brain and studies of the cocaine addict. Ann NY Acad Sci 820: 41-54; discussion 54-55.
47. Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Hitzemann R et al (1997b). Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 386: 830-833.